The Duke CTSI Multidisciplinary Vision Program (MVP) Award provides funding up to $110,000 per award to support novel clinical translational research focused on improving health and healthy equity. Award amounts vary based upon amount requested and budget evaluation by the Program Leadership Committee. Please note that the funding period is from 05/01/2022- 04/30/2023 and that funds must be expended by 04/30/2023. 

Duke CTSI supports translational research endeavors under the following domains:

• Methods/Processes: Scientific study of, and innovation in, the individual steps of the translational process, and its integration into an efficient system of translation from discovery to community.
• Collaboration/Engagement: Research in the structures, rationales, operations, purposes, outcomes, and metrics of engagement with stakeholders at each step of the translational process to elucidate principles and practices that make translation maximally efficient, focused, and relevant.
• Informatics: Development, demonstration, and dissemination of informatics and Information Technology (IT) innovations that accelerate both the science and operations of clinical translation.
• Integration Across the Lifespan: Development of scientific insights, and operational processes that will ensure that translational advances are realized in all populations, including children, pregnant and lactating women, the elderly, and other special populations, with particular emphasis on life stage transitions.
• Workforce Development: Innovations in the substance and culture of translational science workforce development, to create and sustain a robust, supported workforce with the skills, knowledge, and institutional environment necessary for continuous improvement in translational research and science.
   

The Duke Clinical and Translational Science Institute’s (Duke CTSI) mission is to accelerate scientific discoveries to improve health and health equity for patients and communities. Duke CTSI facilitates translational research by providing funding, promoting investigator collaboration, encouraging innovation, providing project management assistance, and providing access to resources/services in a collaborative and service-oriented fashion.

Translational research includes:

• Studies that address mechanisms contributing to human health and health equity, regardless of whether the context of the discovery is the laboratory, individuals, or communities.
• Studies that contribute to improvements in health or health equity by addressing barriers to clinical care or access to care in community or population settings.
• Research that contributes to improved health outcomes or health equity through changes in clinical practice or health policy.

Proposals from teams of investigators from different disciplines are encouraged. Collaborations that bring together ideas, theories, methods and approaches from disparate scientific disciplines are particularly encouraged.

Deadlines:

• Letter of ‘Intent to Submit’ (Mandatory): January 13, 2022
• Application Submission Deadline: February 10, 2022